Authors
Latest:
Cost Analysis of COPD Exacerbations and Cardiovascular Events in SUMMITThis cost analysis using data from the Study to Understand Mortality and Morbidity in COPD (SUMMIT) trial found that fluticasone furoate/vilanterol reduced the rates and costs of combined chronic obstructive pulmonary disease (COPD) exacerbations and revascularization/cardiovascular events versus placebo.
Latest:
Synchronization of Coverage, Benefits, and Payment to Drive InnovationImplementation of payment reform, without a corresponding change to coverage, benefit, and other payment requirements, creates conflicting incentives that may nullify the intended aim of payment reform: to improve health outcomes, while saving costs.
Latest:
Comparative Effectiveness of Early Natalizumab Treatment in JC Virus-Negative Relapsing-Remitting Multiple SclerosisWe estimated the long-term risks and benefits of disease modifying therapies. Benefits were favored by natalizumab with minimal increased risks in the negative anti-JC virus population.
Latest:
Managed Care and Cancer Outcomes for Medicare Beneficiaries With DisabilitiesThis study showed better outcomes for disabled Medicare patients with breast cancer but not those with lung cancer when they were enrolled in HMOs.
Latest:
A Physician-Friendly Alternative to Prior Authorization for Prescription DrugsA policy allowing prescribers to write prior authorization criteria directly on the prescription led to decreased gaps in therapy without diminishing drug cost savings.
Latest:
Financial Incentives and Use of Cesarean Delivery: Taiwan Birth Data 2003 to 2007This study explores whether the policies of financial incentives for the demand and supply sides lowered the Cesarean section rate.
Latest:
Study Summary: DECIDELatest:
Impact of a National Specialty E-Consultation Implementation Project on AccessE-consult implementation grew from 12 to 122 VHA sites with multiple specialties. The adjusted e-consult rate of 1.93/100 consults saved significant patient travel miles and costs.
Latest:
Study Summary: FREEDOMLatest:
Cost-Effectiveness Analysis of Vagal Nerve Blocking for Morbid ObesityThis lifetime economic analysis demonstrates vagal nerve blocking therapy to be a cost-effective alternative to conventional therapy in class 2 and 3 obesity patients.
Latest:
Hypertension Treatment and Control Within an Independent Nurse Practitioner SettingThis cross-sectional retrospective study found comparable blood pressure control rates among patients with hypertension receiving primary care from a nurse practitioner versus a physician.
Latest:
Does Medicare Advantage Enrollment Affect Home Healthcare Use?Medicare Advantage beneficiaries use less home healthcare than do their fee-for-service counterparts, but there is marked regional variation in use by both groups.
Latest:
Cost Savings in Inpatient Oncology Through an Integrative Medicine ApproachAn approach including yoga, holistic nursing, and a "healing environment" can decrease medication use, resulting in substantial cost savings in care of inpatient oncology patients.
Latest:
Healthcare Costs and Nonadherence Among Chronic Opioid UsersHealthcare costs are elevated for patients on chronic opioid therapy; nonadherence to the opioid regimen, based on urine drug monitoring results, further increases costs.
Latest:
Medicare Advantage Enrollees’ Use of Nursing Homes: Trends and Nursing Home CharacteristicsThe share of Medicare Advantage (MA) beneficiaries in the nursing home (NH) population has been steadily rising, while MA plans appear to be increasingly concentrating beneficiaries in select NHs with better performance on quality measures.
